Scintec Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Over the past 12 months, the
Telix Pharmaceuticals Ltd(ASX: TLX) share price has posted massive gains exceeding 150%. The Telix share price kicked off 2020 at $1.53, closed the year at $3.78 and is currently sitting at $3.86 per share.
So what has Telix done to achieve this remarkable pump for its share price?
Significant US Food and Drug Administration (FDA) wins
In January 2020, Telix announced that the US Food and Drug Administration (FDA) approved the recruitment of American participants in the company’s Zirconium Imaging in Renal Cancer Oncology (ZIRCON) study. This was an important milestone because it extended the Phase III study into new territory beyond Australia and Europe. ....

United States , Scott Phillips , Telix Pharmaceuticals Ltd , Drug Administration , Health Canada , Zirconium Imaging , Renal Cancer Oncology , New Drug Application , Scintec Diagnostics , New Drug Submission , ஒன்றுபட்டது மாநிலங்களில் , ஸ்காட் பிலிப்ஸ் , ஆரோக்கியம் கனடா , சிறுநீரகம் புற்றுநோய் புற்றுநோயியல் , புதியது மருந்து விண்ணப்பம் , புதியது மருந்து சமர்ப்பிப்பு ,